Efficacy of different cooling methods for capture-induced hyperthermia in antelope

The capture of wild animals is a stressful event which may cause a capture-induced hyperthermia, resulting in morbidity or mortality. We investigated whether various cooling techniques were effective at lowering the body temperature of hyperthermic animals. To achieve this, we implanted miniature temperature-sensitive data loggers into the abdomens of 12 blesbok (Damaliscus pygargus phillipsi ). Five animals were cooled by dousing with water of different temperatures (4°C, 17°C, 28°C) and fanning after dousing with 28°C water. Seven animals were cooled by ice-packs, a fine mist spray of 28°C water, intravenous (IV) infusion of one litre of 4°C saline solution or 28°C water-dousing. The body temperature after capture was significantly elevated to as high as 41°C to 42°C. Water-dousing interventions significantly decreased minimum body temperature but there was no difference in the minimumbody temperature reached or the magnitude of cooling between the different water temperatures or by the addition of fanning. The ice-packs also lowered body temperature, whereas mist spraying did not.The use of ice packs and dousing with water between 4°C and 28°C were the most effective techniques to reduce capture-induced hyperthermia in blesbok.Water-dousing,when done appropriately, is the most practical and effective method to cool an animal with capture-induced hyperthermia.This study was funded by the National Research Foundation, South Africa.http://www.sawma.co.za/am201

Body temperature, activity patterns and hunting in free-living cheetah : biologging reveals new insights

As one of the few felids that is predominantly diurnal, cheetahs (Acinonyx jubatus) can be exposed to high heat loads in their natural habitat. Little is known about long‐term patterns of body temperature and activity (including hunting) in cheetahs because long‐term concurrent measurements of body temperature and activity have never been reported for cheetahs, or, indeed, for any free‐living felid. We report here body temperature and locomotor activity measured with implanted data loggers over 7 months in 5 free‐living cheetahs in Namibia. Air temperature ranged from a maximum of 39 °C in summer to −2 °C in winter. Cheetahs had higher (∼0.4 °C) maximum 24‐h body temperatures, later acrophase (∼1 h), with larger fluctuations in the range of the 24‐h body temperature rhythm (approximately 0.4 °C) during a hot‐dry period than during a cool‐dry period, but maintained homeothermy irrespective of the climatic conditions. As ambient temperatures increased, the cheetahs shifted from a diurnal to a crepuscular activity pattern, with reduced activity between 900 and 1500 hours and increased nocturnal activity. The timing of hunts followed the general pattern of activity; the cheetahs hunted when they were on the move. Cheetahs hunted if an opportunity presented itself; on occasion they hunted in the midday heat or in total darkness (new moon). Biologging revealed insights into cheetah biology that are not accessible by traditional observer‐based techniques.Supplementary Material: Table S1 Prey identified after 38 successful hunts. Figure S1 An original record of 10‐min recordings of body temperature from a single free‐living female cheetah (female 1, panel B) and the prevailing black globe temperature recorded at a nearby weather station (panel A) over the 7‐month study period (October to May).The National Research Foundation of South Africa and a Carnegie Large Research Grant.https://onlinelibrary.wiley.com/journal/17494877hj2020Paraclinical Science

Study protocol for the recreational stimulation for elders as a vehicle to resolve delirium superimposed on dementia (Reserve For DSD) trial

<p>Abstract</p> <p>Background</p> <p>Delirium is a state of confusion characterized by an acute and fluctuating decline in cognitive functioning. Delirium is common and deadly in older adults with dementia, and is often referred to as delirium superimposed on dementia, or DSD. Interventions that treat DSD are not well-developed because the mechanisms involved in its etiology are not completely understood. We have developed a theory-based intervention for DSD that is derived from the literature on cognitive reserve and based on our prior interdisciplinary work on delirium, recreational activities, and cognitive stimulation in people with dementia. Our preliminary work indicate that use of simple, cognitively stimulating activities may help resolve delirium by helping to focus inattention, the primary neuropsychological deficit in delirium. Our primary aim in this trial is to test the efficacy of Recreational Stimulation for Elders as a Vehicle to resolve DSD (RESERVE- DSD).</p> <p>Methods/Design</p> <p>This randomized repeated measures clinical trial will involve participants being recruited and enrolled at the time of admission to post acute care. We will randomize 256 subjects to intervention (RESERVE-DSD) or control (usual care). Intervention subjects will receive 30-minute sessions of tailored cognitively stimulating recreational activities for up to 30 days. We hypothesize that subjects who receive RESERVE-DSD will have: decreased severity and duration of delirium; greater gains in attention, orientation, memory, abstract thinking, and executive functioning; and greater gains in physical function compared to subjects with DSD who receive usual care. We will also evaluate potential moderators of intervention efficacy (lifetime of complex mental activities and APOE status). Our secondary aim is to describe the costs associated with RESERVE-DSD.</p> <p>Discussion</p> <p>Our theory-based intervention, which uses simple, inexpensive recreational activities for delivering cognitive stimulation, is innovative because, to our knowledge it has not been tested as a treatment for DSD. This novel intervention for DSD builds on our prior delirium, recreational activity and cognitive stimulation research, and draws support from cognitive reserve theory.</p> <p>Trial registration</p> <p>ClinicalTrials.gov identifier: <a href="http://www.clinicaltrials.gov/ct2/show/NCT01267682">NCT01267682</a></p